BRCA2 and ovarian cancer: Although for BRCA2 mutation carriers the p-values did not reach GWAS statistical significance (5x10-8), given the strong prior evidence of association between SNPs in the region and risk for BRCA1 carriers and in the general population we selected the most significant SNPs as associated with ovarian cancer risk.